facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2009
vol. 96
 
Share:
Share:
abstract:
Original paper

Epidermolysis bullosa dystrophica. From clinics to genetics

Agnieszka Sobczyńska-Tomaszewska
,
Katarzyna Wertheim
,
Cezary Kowalewski
,
Anna Kutkowska-Kaźmierczak
,
Katarzyna Woźniak
,
Jerzy Bal

Przegl Dermatol 2009, 96, 227–233
Online publish date: 2009/06/22
View full text Get citation
 
Epidermolysis bullosa dystrophica belongs to a group of genetically determined skin disorders (Epidermolysis bullosa hereditaria) and is caused by mutations in the COL7A1 gene encoding collagen VII. Production of collagen VII with altered physical and chemical properties, or lack of its synthesis, leads to disruption of anchoring fibrils and formation of blisters below the level of the lamina densa. Clinical features of the disease vary from mild, localised skin disorders to severe, generalised disease with poor prognosis. Epidermolysis bullosa dystrophica phenotype as well as inheritance pattern (autosomal dominant or recessive) depend on type of mutation and its localisation in the COL7A1 gene. There are now more than 320 mutations known in the COL7A1 gene. In this paper we present current knowledge about the clinical, therapeutic and genetic aspects of Epidermolysis bullosa dystrophica.
keywords:

EBD, EBHD, COL7A1, genodermatosis



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.